Group 6 Copy 49
0
    Please wait...

    About This Project

    In 2011, scientists developed a unique class of antivirals named DRACOs. DRACO proteins kill cells that are infected with viruses. One limitation to this technology is that DRACO proteins would also kill cells infected with benign viruses. Humans are often infected with benign viruses. We have modified DRACOs to specifically target cells infected with a disease-causing virus without harming regular cells. This novel strategy could be used more broadly against other disease-causing viruses.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Y-DNA A00 and the Peoples of Cameroon: In Search of the Homeland

    This was the first phase of our fundraising campaign to support our fieldwork in Cameroon. We were very successful...

    Genetics of gypsum-endemism and drought tolerance in Sporobolus grass

    Drought threatens sustainability of agriculture throughout the world. A US native gypsum-endemic grass, Sporobolus...

    Campaign Ended

    A biology project funded by 18 people